Enriched clinical annotations |
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched. |
Clinical annotation |
Category |
P-value |
Hits |
Hits(%) |
Module hits in category |
Arrays in annotation |
Arrays |
Hematologic cancer and cell line (Stimulated PBMC) |
Stimulated PBMC |
1.6e-19 |
30 |
54.5 |
55 |
30 |
182 |
Macrophages (Stimulated PBMC) |
Stimulated PBMC |
1.6e-19 |
30 |
54.5 |
55 |
30 |
182 |
Chronic lymphocytic leukemia (B lymphoma) |
B lymphoma |
1.0e-17 |
44 |
43.1 |
102 |
46 |
245 |
Leukemia (B lymphoma) |
B lymphoma |
1.0e-17 |
44 |
43.1 |
102 |
46 |
245 |
Leukemia or leukemia cell line (B lymphoma) |
B lymphoma |
1.0e-17 |
44 |
43.1 |
102 |
46 |
245 |
Liver tissue, cancer or cell line (Liver cancer*) |
Liver cancer* |
1.4e-14 |
88 |
20.9 |
421 |
197 |
1945 |
Lung tissue, cancer or cell line (Lung cancer*) |
Lung cancer* |
2.8e-11 |
175 |
19.9 |
876 |
276 |
1945 |
Liver tissue (Liver cancer*) |
Liver cancer* |
5.1e-11 |
78 |
18.5 |
421 |
187 |
1945 |
Activated B like DLBCL (B lymphoma) |
B lymphoma |
4.1e-10 |
23 |
36.5 |
63 |
30 |
245 |
Diffuse large B cell lymphoma tumor or cell line (B lymphoma) |
B lymphoma |
2.6e-09 |
54 |
85.7 |
63 |
134 |
245 |
Hepatitis infected liver (Liver cancer*) |
Liver cancer* |
8.7e-09 |
64 |
15.2 |
421 |
156 |
1945 |
Follicular lymphoma (B lymphoma) |
B lymphoma |
4.1e-08 |
25 |
24.5 |
102 |
28 |
245 |
Lymphoma or lymphoma cell line (B lymphoma) |
B lymphoma |
4.9e-08 |
59 |
93.6 |
63 |
167 |
245 |
Lung cancer (Lung cancer*) |
Lung cancer* |
5.1e-08 |
146 |
16.6 |
876 |
238 |
1945 |
Lung cancer or cell line (Lung cancer*) |
Lung cancer* |
5.1e-08 |
146 |
16.6 |
876 |
238 |
1945 |
Non small cell lung cancer and cell line (Lung cancer*) |
Lung cancer* |
9.1e-08 |
128 |
14.6 |
876 |
205 |
1945 |
Non small cell lung cancer (Lung cancer*) |
Lung cancer* |
9.1e-08 |
128 |
14.6 |
876 |
205 |
1945 |
Cancer and cell line (Lung cancer*) |
Lung cancer* |
1.3e-07 |
152 |
17.3 |
876 |
252 |
1945 |
Cancer (Lung cancer*) |
Lung cancer* |
1.3e-07 |
152 |
17.3 |
876 |
252 |
1945 |
Diffuse large B cell lymphoma - DLBCL (B lymphoma) |
B lymphoma |
7.5e-07 |
49 |
77.7 |
63 |
126 |
245 |
Hematologic cancer and cell line (Stimulated immune*) |
Stimulated immune* |
1.7e-06 |
27 |
6.4 |
421 |
53 |
1945 |
Hematologic samples and cell lines (Stimulated immune*) |
Stimulated immune* |
1.7e-06 |
27 |
6.4 |
421 |
53 |
1945 |
Macrophages (Stimulated immune*) |
Stimulated immune* |
1.7e-06 |
27 |
6.4 |
421 |
53 |
1945 |
Monocytes (Stimulated immune*) |
Stimulated immune* |
1.7e-06 |
27 |
6.4 |
421 |
53 |
1945 |
Prostate (Prostate cancer*) |
Prostate cancer* |
2.9e-06 |
68 |
7.7 |
876 |
101 |
1945 |
Gram negative bacteria stimulated immune cells (Stimulated PBMC) |
Stimulated PBMC |
3.3e-06 |
37 |
82.2 |
45 |
78 |
144 |
Mutated p53 tumor (Breast cancer) |
Breast cancer |
5.4e-06 |
20 |
83.3 |
24 |
35 |
78 |
B. petrussis stimulated immune cells (Stimulated PBMC) |
Stimulated PBMC |
1.2e-05 |
33 |
73.3 |
45 |
67 |
144 |
Hematologic samples and cell lines (Various tumors) |
Various tumors |
2.9e-05 |
7 |
100 |
7 |
37 |
154 |
Hematologic samples (Various tumors) |
Various tumors |
2.9e-05 |
7 |
100 |
7 |
37 |
154 |
Hematologic samples (B lymphoma) |
B lymphoma |
7.0e-05 |
18 |
17.6 |
102 |
22 |
245 |
Breast cancer cell line (Breast cancer) |
Breast cancer |
0.0001 |
12 |
28.5 |
42 |
17 |
152 |
Grade 1 (Breast cancer) |
Breast cancer |
0.0001 |
7 |
41.1 |
17 |
9 |
85 |
Cell line (Liver cancer) |
Liver cancer |
0.0001 |
11 |
11.7 |
94 |
11 |
207 |
Female hormonal cancer cell line (Breast cancer) |
Breast cancer |
0.0001 |
11 |
26.1 |
42 |
15 |
152 |
Grade 3 (Breast cancer) |
Breast cancer |
0.0002 |
20 |
74.0 |
27 |
38 |
85 |
Normal tissue (Lung cancer) |
Lung cancer |
0.0002 |
22 |
12.5 |
175 |
23 |
276 |
Cancer and cell line (Various tumors*) |
Various tumors* |
0.0002 |
65 |
7.4 |
876 |
105 |
1945 |
Cancer (Various tumors*) |
Various tumors* |
0.0002 |
65 |
7.4 |
876 |
105 |
1945 |
p53 positive hepatocellular carcinoma (Liver cancer) |
Liver cancer |
0.0002 |
18 |
62.0 |
29 |
23 |
60 |
Liver cancer cell line (Liver cancer) |
Liver cancer |
0.0002 |
10 |
10.6 |
94 |
10 |
207 |
Cell line (B lymphoma) |
B lymphoma |
0.0002 |
10 |
15.8 |
63 |
14 |
245 |
Epithelial cell line (NCI60) |
NCI60 |
0.0004 |
25 |
35.2 |
71 |
32 |
139 |
Normal lung tissue (Lung cancer) |
Lung cancer |
0.0004 |
21 |
12 |
175 |
22 |
276 |